ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.

Emilio Cosimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.